Enanta Pharmaceuticals to Participate in Two Investor Conferences in May

Author's Avatar
May 09, 2023

Enanta+Pharmaceuticals%2C+Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in two investor conferences being webcast in May: